Invasive Fungal Disease in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation in China: A Multicenter Epidemiological Study (CAESAR 2.0)
Clinical Infectious Diseases · 30.04.2025 · 80 (4) · 807-816
DOI: 10.1093/cid/ciae612 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Clinical Infectious Diseases, online erschienen am 12.12.2024. Verfasst von Chuan Li und 15 weiteren Autor:innen. Beteiligte Einrichtung: Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Ke…. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Invasive Fungal Infections, Antifungal Agents. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Pfizer.
Abstract (Originalsprache)
Background
This study (China Assessment of Antifungal Therapy in Hematological Diseases [CAESAR 2.0]) aimed to provide updated epidemiological data on invasive fungal disease (IFD) in patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT).
Methods
This multicenter, real-world, observational study was conducted at 12 allo-HSCT centers in China between January and December 2021. Consecutive adult patients (aged ≥18 years) who underwent allo-HSCT with antifungal prophylaxis were included. IFD was diagnosed according to the 2019 criteria of the European Organization for Research and Treatment of Cancer and Mycoses Study Group (EORTC/MSG). Follow-up was completed by 31 December 2022.
Results
A total of 2015 patients were included. Mold-active antifungal prophylaxis was used in 76.08%, most of whom received voriconazole (44.37%) or posaconazole (31.71%). The cumulative incidence of IFD (proven or probable) 1 year after allo-HSCT was 6.3%. Pathogens were identified in 47.97% of IFD cases and mainly included Candida spp. (17.89%), Mucorales (13.01%), Aspergillus spp. (8.94%), and Pneumocystis jirovecii (6.5%). Multivariate analysis identified the following factors associated with IFD: disease at advanced stage (hazard ratio, 2.55 [95% confidence interval, 1.58–4.12]; P < .001), absolute neutrophil count engraftment (≤28 days) (0.37 [15–.92]; P = .03), platelet engraftment (≤28 days) (0.41 [.27–.62]; P < .001), and acute graft-vs-host disease grade III–IV (2.97 [1.97–4.49]; P < .001). The IFD-attributable mortality rate was 48.28%.
Conclusions
Despite the widespread use of mold-active prophylaxis, the risk of IFD after allo-HSCT remains high. The most common pathogens are Candida spp., Mucorales, Aspergillus spp., and P. jirovecii.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, Chin…
- Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.
- Department of Hematology, Division of Life Sciences and Medicine, The First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei, China.
- Department of Hematology, Hematopoietic Stem Cell Transplantation Center, Fujian Institute of Hematology, Fujian Provincial Key Laboratory on Hematology, Fujian Medical University Union Hospital, Fuzhou, China.
- Department of Hematology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
- Department of Hematology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
ORCID-Profile: Jia Chen, Xiao-Xia Hu
Förderung
- National Key Research and Development Program of China
- Pfizer
Zitieren
APA
Li, C., Zhu, D. P., Chen, J., Zhu, X. Y., Li, N. N., Cao, W. J., Zhang, Z. M., Tan, Y. H., Hu, X. X., Yuan, H. L., Fang, X. S., Yin, Y., Wang, H. T., Li, N., Huang, X. J., & Sun, Y. Q. (2025). Invasive Fungal Disease in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation in China: A Multicenter Epidemiological Study (CAESAR 2.0). Clinical Infectious Diseases, 80(4), 807-816. https://doi.org/10.1093/cid/ciae612
Vancouver
Li C, Zhu DP, Chen J, Zhu XY, Li NN, Cao WJ, et al. Invasive Fungal Disease in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation in China: A Multicenter Epidemiological Study (CAESAR 2.0). Clinical Infectious Diseases. 2025;80(4):807-816. doi:10.1093/cid/ciae612
BibTeX
@article{Li2025,
author = {Li, Chuan and Zhu, Dan-Ping and Chen, Jia and Zhu, Xiao-Yu and Li, Nai-Nong and Cao, Wei-Jie and Zhang, Zhong-Ming and Tan, Ye-Hui and Hu, Xiao-Xia and Yuan, Hai-Long and Fang, Xiao-Sheng and Yin, Yue and Wang, Hong-Tao and Li, Nan and Huang, Xiao-Jun and Sun, Yu-Qian},
title = {Invasive Fungal Disease in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation in China: A Multicenter Epidemiological Study (CAESAR 2.0)},
journal = {Clinical Infectious Diseases},
year = {2025},
volume = {80},
number = {4},
pages = {807--816},
doi = {10.1093/cid/ciae612}
}
EUVIMED